Capital Investment Advisors LLC Sells 9,190 Shares of CVS Health Corporation $CVS

Capital Investment Advisors LLC lessened its stake in shares of CVS Health Corporation (NYSE:CVS) by 11.8% in the third quarter, HoldingsChannel.com reports. The firm owned 68,894 shares of the pharmacy operator’s stock after selling 9,190 shares during the quarter. Capital Investment Advisors LLC’s holdings in CVS Health were worth $5,194,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SOA Wealth Advisors LLC. grew its holdings in CVS Health by 36.9% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after acquiring an additional 131 shares during the last quarter. Symmetry Partners LLC boosted its holdings in shares of CVS Health by 2.5% during the third quarter. Symmetry Partners LLC now owns 5,826 shares of the pharmacy operator’s stock worth $439,000 after purchasing an additional 141 shares during the period. Harbor Capital Advisors Inc. grew its stake in shares of CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. HF Advisory Group LLC increased its holdings in CVS Health by 2.9% during the 3rd quarter. HF Advisory Group LLC now owns 5,219 shares of the pharmacy operator’s stock valued at $393,000 after purchasing an additional 145 shares during the period. Finally, United Asset Strategies Inc. raised its position in CVS Health by 1.8% during the 3rd quarter. United Asset Strategies Inc. now owns 8,852 shares of the pharmacy operator’s stock valued at $667,000 after purchasing an additional 154 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 0.4%

Shares of CVS Health stock opened at $80.29 on Friday. The company has a 50-day simple moving average of $78.70 and a two-hundred day simple moving average of $73.83. CVS Health Corporation has a 52-week low of $46.34 and a 52-week high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The stock has a market capitalization of $101.92 billion, a PE ratio of 211.29, a price-to-earnings-growth ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 700.00%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on CVS shares. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Wolfe Research lifted their price target on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, December 8th. Sanford C. Bernstein restated a “market perform” rating and issued a $91.00 price objective on shares of CVS Health in a report on Tuesday. Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Finally, TD Cowen increased their price target on shares of CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.